Oppenheimer analyst Steven Lichtman reiterated a Hold rating on Cooper Co (COO) today and set a price target of $282. The company’s shares opened today at $247.96.
According to TipRanks.com, Lichtman is ranked 0 out of 5 stars with an average return of -7.2% and a 45.4% success rate. Lichtman covers the Healthcare sector, focusing on stocks such as Boston Scientific Corp, Zimmer Biomet Holdings, and Motus Gi Holdings Inc.
Cooper Co has an analyst consensus of Strong Buy, with a price target consensus of $293.14.
See today’s analyst top recommended stocks >>
Cooper Co’s market cap is currently $12.14B and has a P/E ratio of 89.22. The company has a Price to Book ratio of 3.76.
Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is neutral on the stock. Most recently, in September 2018, Thomas A. Bender, a Director at COO sold 7,150 shares for a total of $1,925,855.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
The Cooper Cos, Inc. operates as a medical device company. It operates through the following business units: Cooper Vision and Cooper Surgical. The Cooper Vision business unit brings a refreshing perspective on vision care with a commitment to crafting quality lenses for contact lens wearers.
